The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease

Fadi G. Hage, Rajesh Venkataraman, Gilbert J. Zoghbi, Gilbert J. Perry, Angelo M DeMattos, Ami E. Iskandrian

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

Chronic kidney disease (CKD) affects approximately 13% of the U.S. population and is associated with increased risk of cardiovascular complications. Once renal replacement therapy became available, it became apparent that the mode of death of patients with advanced CKD was more likely than not related to cardiovascular compromise. Further observation revealed that such compromise was related to myocardial disease (related to hypertension, stiff vessels, coronary heart disease, or uremic toxins). Early on, the excess of cardiovascular events was attributed to accelerated atherosclerosis, inadequate control of blood pressure, lipids, or inflammatory cytokines, or perhaps poor glycemia control. In more recent times, outcome research has given us further information that relates even lesser degrees of renal compromise to an excess of cardiovascular events in the general population and in those with already present atherosclerotic disease. As renal function deteriorates, certain physiologic changes occur (perhaps due to hemodynamic, inflammatory, or metabolic changes) that decrease oxygen-carrying capacity of the blood by virtue of anemia, make blood vessels stiffer by altering collagen or through medial calcinosis, raise the blood pressure, increase shearing stresses, or alter the constituents of atherosclerotic plaque or the balance of thrombogenesis and thrombolysis. At further levels of renal dysfunction, tangible metabolic perturbations are recognized as requiring specific therapy to reduce complications (such as for anemia and hyperparathyroidism), although outcome research to support some of our current guidelines is sorely lacking. Understanding the process by which renal dysfunction alters the prognosis of cardiac disease might lead to further methods of treatment. This review will outline the relationship of CKD to coronary heart disease with respect to the current understanding of the traditional and nontraditional risk factors, the role of various imaging modalities, and the impact of coronary revascularization on outcome.

Original languageEnglish (US)
Pages (from-to)2129-2140
Number of pages12
JournalJournal of the American College of Cardiology
Volume53
Issue number23
DOIs
StatePublished - Jun 9 2009

Fingerprint

Chronic Renal Insufficiency
Coronary Disease
Kidney
Anemia
Outcome Assessment (Health Care)
Blood Pressure
Calcinosis
Renal Replacement Therapy
Hyperparathyroidism
Conservation of Natural Resources
Atherosclerotic Plaques
Cardiomyopathies
Population
Blood Vessels
Heart Diseases
Atherosclerosis
Collagen
Hemodynamics
Observation
Guidelines

Keywords

  • chronic kidney disease
  • coronary heart disease
  • imaging
  • revascularization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease. / Hage, Fadi G.; Venkataraman, Rajesh; Zoghbi, Gilbert J.; Perry, Gilbert J.; DeMattos, Angelo M; Iskandrian, Ami E.

In: Journal of the American College of Cardiology, Vol. 53, No. 23, 09.06.2009, p. 2129-2140.

Research output: Contribution to journalArticle

Hage, Fadi G. ; Venkataraman, Rajesh ; Zoghbi, Gilbert J. ; Perry, Gilbert J. ; DeMattos, Angelo M ; Iskandrian, Ami E. / The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease. In: Journal of the American College of Cardiology. 2009 ; Vol. 53, No. 23. pp. 2129-2140.
@article{a07744255bc5493082097029306d02e0,
title = "The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease",
abstract = "Chronic kidney disease (CKD) affects approximately 13{\%} of the U.S. population and is associated with increased risk of cardiovascular complications. Once renal replacement therapy became available, it became apparent that the mode of death of patients with advanced CKD was more likely than not related to cardiovascular compromise. Further observation revealed that such compromise was related to myocardial disease (related to hypertension, stiff vessels, coronary heart disease, or uremic toxins). Early on, the excess of cardiovascular events was attributed to accelerated atherosclerosis, inadequate control of blood pressure, lipids, or inflammatory cytokines, or perhaps poor glycemia control. In more recent times, outcome research has given us further information that relates even lesser degrees of renal compromise to an excess of cardiovascular events in the general population and in those with already present atherosclerotic disease. As renal function deteriorates, certain physiologic changes occur (perhaps due to hemodynamic, inflammatory, or metabolic changes) that decrease oxygen-carrying capacity of the blood by virtue of anemia, make blood vessels stiffer by altering collagen or through medial calcinosis, raise the blood pressure, increase shearing stresses, or alter the constituents of atherosclerotic plaque or the balance of thrombogenesis and thrombolysis. At further levels of renal dysfunction, tangible metabolic perturbations are recognized as requiring specific therapy to reduce complications (such as for anemia and hyperparathyroidism), although outcome research to support some of our current guidelines is sorely lacking. Understanding the process by which renal dysfunction alters the prognosis of cardiac disease might lead to further methods of treatment. This review will outline the relationship of CKD to coronary heart disease with respect to the current understanding of the traditional and nontraditional risk factors, the role of various imaging modalities, and the impact of coronary revascularization on outcome.",
keywords = "chronic kidney disease, coronary heart disease, imaging, revascularization",
author = "Hage, {Fadi G.} and Rajesh Venkataraman and Zoghbi, {Gilbert J.} and Perry, {Gilbert J.} and DeMattos, {Angelo M} and Iskandrian, {Ami E.}",
year = "2009",
month = "6",
day = "9",
doi = "10.1016/j.jacc.2009.02.047",
language = "English (US)",
volume = "53",
pages = "2129--2140",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "23",

}

TY - JOUR

T1 - The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease

AU - Hage, Fadi G.

AU - Venkataraman, Rajesh

AU - Zoghbi, Gilbert J.

AU - Perry, Gilbert J.

AU - DeMattos, Angelo M

AU - Iskandrian, Ami E.

PY - 2009/6/9

Y1 - 2009/6/9

N2 - Chronic kidney disease (CKD) affects approximately 13% of the U.S. population and is associated with increased risk of cardiovascular complications. Once renal replacement therapy became available, it became apparent that the mode of death of patients with advanced CKD was more likely than not related to cardiovascular compromise. Further observation revealed that such compromise was related to myocardial disease (related to hypertension, stiff vessels, coronary heart disease, or uremic toxins). Early on, the excess of cardiovascular events was attributed to accelerated atherosclerosis, inadequate control of blood pressure, lipids, or inflammatory cytokines, or perhaps poor glycemia control. In more recent times, outcome research has given us further information that relates even lesser degrees of renal compromise to an excess of cardiovascular events in the general population and in those with already present atherosclerotic disease. As renal function deteriorates, certain physiologic changes occur (perhaps due to hemodynamic, inflammatory, or metabolic changes) that decrease oxygen-carrying capacity of the blood by virtue of anemia, make blood vessels stiffer by altering collagen or through medial calcinosis, raise the blood pressure, increase shearing stresses, or alter the constituents of atherosclerotic plaque or the balance of thrombogenesis and thrombolysis. At further levels of renal dysfunction, tangible metabolic perturbations are recognized as requiring specific therapy to reduce complications (such as for anemia and hyperparathyroidism), although outcome research to support some of our current guidelines is sorely lacking. Understanding the process by which renal dysfunction alters the prognosis of cardiac disease might lead to further methods of treatment. This review will outline the relationship of CKD to coronary heart disease with respect to the current understanding of the traditional and nontraditional risk factors, the role of various imaging modalities, and the impact of coronary revascularization on outcome.

AB - Chronic kidney disease (CKD) affects approximately 13% of the U.S. population and is associated with increased risk of cardiovascular complications. Once renal replacement therapy became available, it became apparent that the mode of death of patients with advanced CKD was more likely than not related to cardiovascular compromise. Further observation revealed that such compromise was related to myocardial disease (related to hypertension, stiff vessels, coronary heart disease, or uremic toxins). Early on, the excess of cardiovascular events was attributed to accelerated atherosclerosis, inadequate control of blood pressure, lipids, or inflammatory cytokines, or perhaps poor glycemia control. In more recent times, outcome research has given us further information that relates even lesser degrees of renal compromise to an excess of cardiovascular events in the general population and in those with already present atherosclerotic disease. As renal function deteriorates, certain physiologic changes occur (perhaps due to hemodynamic, inflammatory, or metabolic changes) that decrease oxygen-carrying capacity of the blood by virtue of anemia, make blood vessels stiffer by altering collagen or through medial calcinosis, raise the blood pressure, increase shearing stresses, or alter the constituents of atherosclerotic plaque or the balance of thrombogenesis and thrombolysis. At further levels of renal dysfunction, tangible metabolic perturbations are recognized as requiring specific therapy to reduce complications (such as for anemia and hyperparathyroidism), although outcome research to support some of our current guidelines is sorely lacking. Understanding the process by which renal dysfunction alters the prognosis of cardiac disease might lead to further methods of treatment. This review will outline the relationship of CKD to coronary heart disease with respect to the current understanding of the traditional and nontraditional risk factors, the role of various imaging modalities, and the impact of coronary revascularization on outcome.

KW - chronic kidney disease

KW - coronary heart disease

KW - imaging

KW - revascularization

UR - http://www.scopus.com/inward/record.url?scp=66149084047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149084047&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2009.02.047

DO - 10.1016/j.jacc.2009.02.047

M3 - Article

C2 - 19497438

AN - SCOPUS:66149084047

VL - 53

SP - 2129

EP - 2140

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 23

ER -